Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer… EP News Bureau Mar 19, 2025 Cellogen Therapeutics has secured $2 million in funding from NATCO Pharma and is preparing for clinical trials in collaboration…
